Dato: 04-11-2016 11:28 CET Opprinnelig tittel på pressemeldingen: Takeda to implement three CSR programs focusing on solutions to maternal and child healthcare problems in Africa and Asia. Kategori: , Helse Legemiddel kosttilskudd Osaka, Japan, November 2, 2016 —
CSR Programs Focusing on Maternal and Child Health
-Evolving Around the Priority Theme of Preventive Activities Contributing to the Health of People in Developing/Emerging Countries-
Osaka, Japan, November 2, 2016 — Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the company will implement three CSR programs focusing on solutions to maternal and child healthcare problems in Africa and Asia. These programs are implemented to addressing critical issues in maternal and child health in medium- to long-term perspectives, in partnership with international NGOs with a proven track record: World Vision Japan, Save the Children Japan, and Plan International Japan.
Starting from fiscal year 2016, Takeda has been focusing on prevention for health in developing and emerging countries, as a priority theme in its CSR activities. The contents of these programs are in line with our priority theme and will also contribute to helping achieve “Goal 3: Ensuring healthy lives and promoting the well-being for all at all ages” of the Sustainable Development Goals (SDGs)* adopted by the United Nations General Assembly in 2015.
◆ Project Outline and Implementing Organizations
Partner Program outline Area Period Budget
1 World Vision Japan Community Health Worker Training for Maternal and Child Health India, Bangladesh,Nepal, Afghanistan 5 years Approx. ¥500 million
2 Save the Children Japan Maternal and Newborn Health for Ethnic Minorities Myanmar, Vietnam, Laos 5 years Approx. ¥250 million
3 Plan International Japan Digital Birth Registration Kenya 3 years Approx. ¥100 million
As a pharmaceutical company committed to improving people’s lives, Takeda strives better health for people worldwide through leading innovation in medicine. At the same time, the company will continue to contribute to society by supporting patients and their families who cannot be sufficiently supported by the provision of pharmaceutical products alone.
* Sustainable Development Goals (SDGs): International goals for sustainable development included in the “2030 Agenda for Sustainable Development” adopted by the United Nations in September 2015. SDGs consist of 17 goals and 169 targets. http://www.un.org/sustainabledevelopment/sustainable-development-goals/
Overview of the Programs by Partner
1. World Vision Japan: Community Health Worker Training for Maternal and Child Health■ Overview : In Southern Asia which has a high infant mortality rate compared with other , this program will build the capacity of 1,400 community health workers to reduce preventative death among mothers and children by providing some 500,000 people with knowledge and services related to healthcare over five years.■ : India, Bangladesh, Nepal and Afghanistan■ Period : 5 years■ Budget : Approx. ¥500 million
2. Save the Children Japan: Maternal and Newborn Health for Ethnic Minorities■ Overview : This program aims to improve the access and quality of health care for minority populations in Asia. Working in close collaboration with the relevant health authorities, the program will provide health education, training, and services over five years, to 150,000 local residents which include 40,000 ethnic minority women and children, and health care providers.■ : Myanmar, Vietnam and Laos■ Period : 5 years■ Budget : Approx. ¥250 million
3. Plan International Japan: Digital Birth Registration■ Overview : Takeda supports efforts to introduce digital birth registration in rural areas in Kenya, where registration rates are low. The program will help to protect children's basic human rights and will contribute to improving healthcare access by providing a system that enables them to receive healthcare services such as immunizations.■ Region : Kenya■ Period : 3 years■ Budget : Approx. ¥100 million
About World Vision
Inspired by our Christian values, we are dedicated to working with the world’s most vulnerable people, especially with children, World Vision Japan is one of the support offices of World Vision who works in about 100 countries and is registered with UN ECOSOC.About Save the Children JapanSave the Children is an independent international organization and is a pioneer with one hundred years of history in the field of child rights. Today, Save the Children provides support in approximately 120 countries, in partnership with independent member organizations in 29 countries including Japan to deliver lasting results for children. Save the Children Japan was established in 1986.About Plan International JapanPlan International is an independent child rights and humanitarian organization committed to children living a life free of poverty, violence and injustice. Plan places a specific focus on girls and women, who are most often left behind. When disasters or conflict threatens children’s lives and well-being, Plan is quick to respond. Together, we are transforming lives.About Takeda CSR ActivitiesFor Takeda, CSR is rooted in putting the patient in the center and operating a pharmaceutical business that creates outstanding products. In addition, we strive to maintain and improve sound business processes, and to engage in activities to promote a sustainable society as a good corporate citizen. In doing so, we are implementing a model of value creation and preservation through CSR. This will help us to build trust with society, reinforce our reputation, and further develop the pharmaceutical business.
For more information, visit http://www.takeda.com/csr/policy/
Media Contacts:Tsuyoshi [email protected]+81 (0) 3-3278-2417 Kilde: Pressekontor Takeda AS – PRESSEMELDING – ———— Takeda (TSE: 4502) er et forskningsbasert, globalt selskap med hovedvekt på legemidler. Selskapet er til stede i mer enn 70 markeder og satser blant annet innen spesialområder som kreft, mage/tarm og vaksiner.
Som det største farmasøytiske selskapet i Japan, og et av de ledende globale selskapene i industrien, arbeider Takeda, gjennom medisinsk innovasjon, for bedre helse for pasienter over hele verden.
I Norge har Takeda cirka 280 medarbeidere og et eget produksjonsanlegg i Asker utenfor Oslo. Målt i volum er Takeda landets største leverandør av legemidler. Takeda har et bredt spekter av reseptbelagte medisiner til sykehus, spesialister og allmennpraktiserende leger. Takedas reseptfrie medisiner og kosttilskudd selges i apotek.
Takeda kjøpte i 2011 Nycomed, som har vært en ledende aktør i norsk legemiddelindustri og en viktig del av nordmenns hverdag i over 140 år. Selskapet har skapt, utviklet og produsert flere av landets mest kjente legemidler. Den arven skal Takeda bygge videre på og jobbe for bedre helse og et friskere Norge.
Mer informasjon om Takeda på www.takeda.com
Mer informasjon om Takeda Norge på www.takeda.no Hashtags: # #Helse Legemiddel kosttilskudd Helse Legemiddel kosttilskudd
